FDA Inspection 1027867 — IntegoGen, LLC
The FDA completed an inspection of IntegoGen, LLC on June 12, 2017 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 12, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Tallahassee, FL (United States)